Back to News
Market Impact: 0.45

JMP maintains Caesars stock $45 target amid booking trends

CZRMGM
Analyst InsightsCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookTravel & LeisureMarket Technicals & Flows
JMP maintains Caesars stock $45 target amid booking trends

JMP Securities reiterated its Market Outperform rating for Caesars Entertainment (CZR) with a $45 price target, citing successful pricing strategies in non-gaming segments and a positive outlook for convention and group bookings, which are expected to grow. This positive stance comes despite mixed Q1 earnings, with a normalized EPS of -$0.48 missing estimates, though revenue slightly exceeded expectations at $2.79 billion, and varying analyst opinions reflected in price target adjustments from $28 to $62. While summer bookings show some softness, analysts believe Caesars' strategic initiatives, including non-gaming expansion and a focus on reducing leverage, position it well for medium-term growth.

Analysis

JMP Securities has maintained its Market Outperform rating and a $45.00 price target for Caesars Entertainment (CZR), currently trading at $26.74 with a $5.6 billion market capitalization, highlighting successful pricing strategies in non-gaming segments despite some observed softness in summer bookings due to a shortening booking window. This optimism is partly rooted in the convention and group outlook, which has seen a 2% year-to-date increase and is anticipated to be a medium-term catalyst, potentially reaching record levels by 2026 and accounting for 15-20% of business. Caesars, with annual revenue of $11.3 billion and EBITDA of $3.6 billion, is leveraging favorable hotel supply levels and non-gaming expansion, including sports, to bolster its financial position, although it operates with significant debt obligations. The company's first-quarter normalized EPS of -$0.48 missed Wall Street expectations, while revenue of $2.79 billion slightly exceeded forecasts, and its digital segment reported a notable 19% year-over-year revenue increase. Other analysts present a mixed view: CFRA downgraded CZR to Hold with a $30 target, citing balance sheet and macroeconomic concerns, while Stifel reduced its target to $42 but maintained a Buy rating, worried about consumer spending and debt. InvestingPro's Fair Value analysis indicates the stock is slightly undervalued. Management remains confident in the U.S. consumer, expects a Q4 2025 boost from a strong convention lineup, and is focused on reducing leverage.